Jane Wasman, President, International and GC at ACORDA THERAPEUTICS INC (ACOR), sold 13,797 shares at $43.00 ($585K) on 2015-12-22, disclosed to the SEC on 2015-12-24.
Scheduled sale ($585k) by President, International and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.07 | 8,455 | $356K | 60.8% |
| 2 | $43.00 | 5,342 | $230K | 39.2% |
| Total | $42.43 avg | 13,797 | $585K | 100% |
| Filing → |
| ACOR | SELL | 2018-12-06 | $126K | — | Filing → |
| ACOR | SELL | 2018-01-23 | $1.9M | — | Filing → |
| ACOR | SELL | 2017-12-05 | $187K | — | Filing → |